Lassen, U. et al. 2011. A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas. Acta Oncologica. 50, 3 (Apr. 2011), 448–454. DOI:https://doi.org/10.3109/0284186X.2010.500300.